A representative diagnostic of a single-location aesthetic practice in the $2.5–3M revenue band. The data is composite. The format is what you receive when you book your own.
This composite practice runs a healthy book of injectables and skin-care treatments through Boulevard, an email tool that's wired but rarely used, and a manual review process. By every standard the practice would consider, it is doing well. But across seven categories of audit, the diagnostic surfaced six measurable gaps where repeat revenue is leaking — gaps the practice's own systems aren't designed to see.¹
The largest gap, by estimated annual impact, is treatment-plan rebooking: 47% of injectables patients leave the chair without a return appointment booked. The second-largest is GLP-1 cross-conversion.² The smallest, by dollars, is inventory expiration risk — but it is the easiest to close.
Total estimated annual recovery, summed across all six gaps and rounded for prudence: $147,600. The figure is supported by per-gap methodology shown in the body of this document. Three routes to close it follow at the end.³
The aggregate of six gaps, sourced and footnoted in the body of this scorecard.
Every Sculptrix scorecard walks the same seven categories so the math is comparable across practices. The status to the right of each row reflects what we found in this composite.
Each gap is presented in the same format: severity, category, what we found, why it matters, estimated annual impact, and the source of the math.
Across the last 12 months of injectables visits, 47% of patients leave the chair without their next appointment booked. The booking system records the visit. The follow-up tool sends a generic "thank you." Neither system knows the patient is now on a 90-day Botox cycle, a 6-month filler cycle, or a 3-visit laser series. The cycle resumes only if the patient remembers — or if a competitor's marketing reaches them first.
The practice carries an 18% combined cancellation + no-show rate, which is on the higher end but not unusual. What is unusual is that almost none of those slots refill. There is no waitlist activation. The receptionist is not paged. The slot becomes idle, and idle slots cost the practice their full average ticket value.
Over the last 12 months, the practice received 38 GLP-1-related referrals or new-patient inquiries. Of those, only 4 returned for any second service — an 11% conversion rate against an industry benchmark of roughly 13%. The gap is not unusual; the cost of leaving it unaddressed is. Each non-returning GLP-1 patient is foregoing an average of 2.4 follow-on services across an 18-month window.
The practice runs a quarterly membership program with ~120 active members. Across the last quarter, 22% of members did not use the full benefit they paid for. The unused benefits roll off without notification. The practice keeps the revenue, but underutilized members are the leading indicator of churn — and replacing a churned member costs roughly 4× the recovery of activating an underutilizer.
The practice averages 0.4 new Google reviews per week against an aesthetic-vertical benchmark of roughly 2.1/week for active practices. The review-request flow is manual: the receptionist asks happy patients verbally at checkout. There is no follow-up. The star rating is healthy (4.7), but trailing 90-day visibility on local search is decaying because new-review velocity is the dominant ranking signal.
The practice is well-stocked, often on the high side. Three partial vials of injectable product expired in the last 90 days because no system flagged them as approaching expiration in time to schedule patients into them. The dollars are modest. The pattern is the indicator: the operational layer running the practice's stock is the receptionist's memory.
Every Sculptrix scorecard names three routes, in order of effort. We don't recommend a route we can't quantify — and we name the route we'd take ourselves last, even when it's ours.
Continue running the practice the way it runs today. Most of these gaps will not heal on their own.
Document the processes. Train the front desk. Build manual nudges in Boulevard. Track every patient cycle by hand.
Seven modules of the Practice Intelligence Layer, deployed on top of your existing Boulevard, email tool, and review process. Sculptrix runs the work in the background.
Every figure in this scorecard is sourced. The seven audit categories are walked the same way for every practice; the per-gap math varies based on the practice's actual data. What follows is the methodology applied to this composite.
Patient retention & treatment cycle. Email & communication. Booking & scheduling. No-show & confirmation. Reviews & reputation. Inventory & supply. Membership & package. Each category contains six to eight checkpoints — forty-eight in total — drawn from a published checklist that has not changed since this scorecard format was first issued.⁴
The composite practice's own data: 12 months of Boulevard reports (rebooking, cancellation, no-show), 90 days of schedule audit, 12 months of Google Business Profile review log, 90 days of inventory walk, 90 days of membership-utilization report. Industry benchmarks layered on top of those data: Allergan Aesthetics 2024 GLP-1 retention work, McKinsey 2024 medical-aesthetics report, AmSpa 2025 industry survey, BrightLocal aesthetics-vertical review benchmarks.⁵
We did not access the practice's PMS directly. We did not see patient records, contact details, or treatment notes. The diagnostic was performed against operational metadata: counts, rates, dates, statuses. The Pattern 2 architecture that governs the platform is the same architecture that governs the audit — protected health information stays inside the practice management system at every step.⁶
The practice in this scorecard is composite. The numbers were drawn from a representative blend of aesthetic practices in the $2.5–3M revenue band, calibrated against industry benchmarks (Allergan Aesthetics, McKinsey, BrightLocal), and rounded for prudence.
When you book your own scorecard, the format is identical. The numbers will be specific to your practice — sourced from your Boulevard, your email tool, your review log, and the operational walk-through we run together. We will tell you, in writing, where each estimate came from. We will tell you, in writing, the route we'd take if we were you. We will tell you the route to walk away from us if that's the right move.
The scorecard is yours either way.
A diagnostic before a decision. $500 flat.
Request my Scorecard →This volume is one of an ongoing series. The Patient Retention Scorecard is published in editions, dated, footnoted, and signed. The format does not change; the practice does. The next edition is the one we prepare for you.